Stephen George Dilly, President and CEO at Aimmune Therapeutics, Inc. (AIMT), sold 58,914 shares at $30.83 ($1.8M) on 2018-06-11, disclosed to the SEC on 2018-06-13.
Open-market sale of $1.8M AIMT by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.83 | 29,457 | $908K | 50.0% |
| 2 | $30.83 | 29,457 | $908K | 50.0% |
| Total | $30.83 avg | 58,914 | $1.8M | 100% |
| Filing → |
| SRRA | BUY | 2021-05-20 | $178K | — | Filing → |
| SGMO | SELL | 2020-03-20 | $210K | — | Filing → |
| SGMO | SELL | 2020-03-18 | $90K | — | Filing → |